Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: FIBROBLAST GROWTH FACTOR-23, . Treffer: 8
2023
Zittermann, A; Pilz, S; Morshuis, M; Gummert, F; Milting, H
Vitamin D deficiency and driveline infection in patients with a left ventricular assist device implant.
Int J Artif Organs. 2023; 46(4):235-240
Doi: 10.1177/03913988231154939
Web of Science
PubMed
FullText
FullText_MUG
2019
Fandler-Höfler, S; Enzinger, C; Kneihsl, M; Pinter, D; Eppinger, S; Obermayer-Pietsch, B; Goritschan, A; Hafner-Giessauf, H; Rosenkranz, AR; Fazekas, F; Gattringer, T
Early renal dysfunction and fibroblast growth factor-23 in patients with small vessel disease-related stroke.
Sci Rep. 2019; 9(1):15410-15410
Doi: 10.1038/s41598-019-51965-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Trummer, C; Schwetz, V; Pandis, M; Grübler, MR; Verheyen, N; Gaksch, M; Zittermann, A; März, W; Aberer, F; Steinkellner, J; Friedl, C; Brandenburg, V; Voelkl, J; Alesutan, I; Obermayer-Pietsch, B; Pieber, TR; Tomaschitz, A; Pilz, S
Effects of vitamin D supplementation on FGF23: a randomized-controlled trial.
Eur J Nutr. 2019; 58(2):697-703
Doi: 10.1007/s00394-018-1672-7
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2016
Verheyen, N; Fahrleitner-Pammer, A; Pieske, B; Meinitzer, A; Belyavskiy, E; Wetzel, J; Gaksch, M; Grübler, MR; Catena, C; Sechi, LA; Van, Ballegooijen, AJ; Brandenburg, VM; Scharnagl, H; Perl, S; Brussee, H; März, W; Pilz, S; Tomaschitz, A
Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial.
J Hypertens. 2016; 34(9):1778-86
Doi: 10.1097/HJH.0000000000001004
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Zittermann, A; Morshuis, M; Kuhn, J; Pilz, S; Ernst, JB; Oezpeker, C; Dreier, J; Knabbe, C; Gummert, JF; Milting, H
Vitamin D metabolites and fibroblast growth factor-23 in patients with left ventricular assist device implants: association with stroke and mortality risk.
Eur J Nutr. 2016; 55(1):305-313
Doi: 10.1007/s00394-015-0847-8
Web of Science
PubMed
FullText
FullText_MUG
2015
Schneider, A; Schneider, MP; Krieter, DH; Genser, B; Scharnagl, H; Stojakovic, T; Wanner, C; Drechsler, C
Effect of High-Flux Dialysis on Circulating FGF-23 Levels in End-Stage Renal Disease Patients: Results from a Randomized Trial.
PLoS One. 2015; 10(5):e0128079-e0128079
Doi: 10.1371/journal.pone.0128079
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2013
Staude, H; Jeske, S; Schmitz, K; Warncke, G; Fischer, DC
Cardiovascular risk and mineral bone disorder in patients with chronic kidney disease.
Kidney Blood Press Res. 2013; 37(1):68-83
Doi: 10.1159/000343402
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2007
Hesse, M; Fröhlich, LF; Zeitz, U; Lanske, B; Erben, RG
Ablation of vitamin D signaling rescues bone, mineral, and glucose homeostasis in Fgf-23 deficient mice.
Matrix Biol. 2007; 26(2): 75-84.
Doi: 10.1016/j.matbio.2006.10.003
Web of Science
PubMed
FullText
FullText_MUG